Skip to main content
. 2023 Dec 25;115(2):589–599. doi: 10.1111/cas.16053

FIGURE 2.

FIGURE 2

Cumulative incidence of CRN progression (A) and overall survival (B) between the low‐dose group and the high‐dose group.